Eterna Therapeutics
ERNA
#10453
Rank
A$9.83 M
Marketcap
A$0.34
Share price
-11.55%
Change (1 day)
-94.56%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): A-$111.33

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is A-$110.08. In 2022 the company made an earnings per share (EPS) of A-$180.60 an increase over its 2021 EPS that were of A-$1,193.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$111.33
2022A-$180.60-84.86%
2021A-$1,193

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.96-102.69%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
A-$0.95-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
A-$2.90-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A-$0.17-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
A$1.78-101.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
A$0.75-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA